Using earlier measures in a longitudinal sequence as a potential surrogate for a later one
From MaRDI portal
Publication:962388
DOI10.1016/j.csda.2009.11.024zbMath1464.62143OpenAlexW2039690049MaRDI QIDQ962388
Geert Molenberghs, Ariel Alonso, Assam Pryseley, Abel Tilahun
Publication date: 6 April 2010
Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)
Full work available at URL: http://hdl.handle.net/1942/10891
Computational methods for problems pertaining to statistics (62-08) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Related Items (2)
Monitoring phase II comparative clinical trials with two endpoints and penalty for adverse events ⋮ Evaluation of longitudinal surrogate markers
Cites Work
- Unnamed Item
- Longitudinal data analysis using generalized linear models
- Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS
- The evaluation of surrogate endpoints.
- Models for discrete longitudinal data.
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements: Canonical Correlation Approach
- Simplified hierarchical linear models for the evaluation of surrogate endpoints
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Approximate Inference in Generalized Linear Mixed Models
- General class of covariance structures for two or more repeated factors in longitudinal data analysis
- Validation of Surrogate Markers in Multiple Randomized Clinical Trials with Repeated Measurements
- Linear mixed models for longitudinal data
This page was built for publication: Using earlier measures in a longitudinal sequence as a potential surrogate for a later one